| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/24/2008 | WO2008083256A3 Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof |
| 12/24/2008 | WO2008076685A3 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 12/24/2008 | WO2008070692A8 Bicyclic compounds and use as antidiabetics |
| 12/24/2008 | WO2008070039A3 3 beta-hydroxysteroid dehydrogenase inhibitors |
| 12/24/2008 | WO2008067549A3 Stabilized zolpidem pharmaceutical compositions |
| 12/24/2008 | WO2008067526A3 Compositions and methods of sphingosine kinase inhibitors in radiation therapy of various cancers |
| 12/24/2008 | WO2008066775A3 Compositions and methods to reduce fat and retract skin |
| 12/24/2008 | WO2008066634A3 Method of treqatment and compositions of d-chriro inositol and phosphates thereof |
| 12/24/2008 | WO2008064264A8 In vivo methods for identifying and screening compounds that modulate calstabin binding to a ryanodine receptor |
| 12/24/2008 | WO2008062209A3 Dissolution and processing of cellulose |
| 12/24/2008 | WO2008060476A3 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 12/24/2008 | WO2008060372A3 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 12/24/2008 | WO2008058167A3 Method for treating disorders associated with complement activation |
| 12/24/2008 | WO2008057856A3 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 12/24/2008 | WO2008055870A8 Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 12/24/2008 | WO2008054711A3 Combined telomerase inhibitor and gemcitabine for the treatment of cancer |
| 12/24/2008 | WO2008051291A3 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 12/24/2008 | WO2008048866A3 Bicyclic heteroaromatic compounds |
| 12/24/2008 | WO2008042806A3 Stilbenedisulfonic acid derivatives as inhibitors of retroviral integrase |
| 12/24/2008 | WO2008039642A3 Methods and compounds for treatment of clostridium based infection |
| 12/24/2008 | WO2008033748A3 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 12/24/2008 | WO2008024763A3 Identification and characterization of hcv replicon variants with reduced susceptibility to hcv-796, and methods related thereto |
| 12/24/2008 | WO2008021463A3 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 12/24/2008 | WO2008021088A3 Salicylanilides enhance oral delivery of therapeutic peptides |
| 12/24/2008 | WO2008019010A3 Method of treating thermoregulatory disfunction with paroxetine |
| 12/24/2008 | WO2008017670A8 Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| 12/24/2008 | WO2008014338A3 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 12/24/2008 | WO2008014008A3 Compositions and methods for modulating angiogenesis |
| 12/24/2008 | WO2008013851A3 Processes for preparing polymorphic forms of solifenacin succinate |
| 12/24/2008 | WO2008013840A3 Erastin analogs and uses thereof |
| 12/24/2008 | WO2008009078A3 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| 12/24/2008 | WO2008009077A3 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
| 12/24/2008 | WO2008008553A3 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 12/24/2008 | WO2007146248A3 Stable laquinimod preparations |
| 12/24/2008 | WO2007144048A3 Presentation form for the oral administration of phenothiazine dyes, its production and use |
| 12/24/2008 | WO2007140002A3 Method for treating non-hodgkin's lymphoma |
| 12/24/2008 | WO2007139951A3 Method for treating proliferative disorders associated with protooncogene products |
| 12/24/2008 | WO2007133712A3 Antimicrobial therapy for bacterial infections |
| 12/24/2008 | WO2007121326A3 Compositions and methods for modulating gene expression |
| 12/24/2008 | WO2007117653A3 Cdk9-pi3k-akt inhibitors for cancer treatment |
| 12/24/2008 | WO2007109097A3 RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF |
| 12/24/2008 | WO2007095631A3 New drug delivery system for crossing the blood brain barrier |
| 12/24/2008 | WO2007092326A3 Inhibition of hiv infection through chemoprophylaxis |
| 12/24/2008 | WO2007089926A3 Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| 12/24/2008 | WO2007084233A3 Pharmaceutical formulations comprising 17-allylamino-17-demethoxygeldanamycin |
| 12/24/2008 | WO2007067637A3 Cartilage repair methods |
| 12/24/2008 | WO2006102610A3 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 12/24/2008 | EP2006303A1 Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof |
| 12/24/2008 | EP2006300A2 Characterization of a calcium channel family |
| 12/24/2008 | EP2006287A1 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient |
| 12/24/2008 | EP2006286A2 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11 beta -hydroxysteroid dehydrogenase type i |
| 12/24/2008 | EP2006284A1 Dicyclooctane derivates, preparation processes and medical uses thereof |
| 12/24/2008 | EP2006271A2 Substituted bicyclic cyclic derivative and use thereof |
| 12/24/2008 | EP2005968A2 Nanocomposite particle |
| 12/24/2008 | EP2005964A2 The medicament for treating hyperphospheremia and preparation thereof |
| 12/24/2008 | EP2005962A2 Therapeutic agent for inflammatory bowel disease |
| 12/24/2008 | EP2005961A1 Method of optimizing the treatment of chronic myeloid leukemia with Abl tyrosine kinase inhibitors |
| 12/24/2008 | EP2005959A1 External pharmaceutical composition |
| 12/24/2008 | EP2005958A1 External pharmaceutical composition |
| 12/24/2008 | EP2005956A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical |
| 12/24/2008 | EP2005955A1 Formulation of unsaturated salt of ampelopsin and its application |
| 12/24/2008 | EP2005954A2 Kit for cancer therapy and pharmaceutical composition for cancer therapy |
| 12/24/2008 | EP2005952A1 Tamsulosin-containing percutaneous absorption type preparation |
| 12/24/2008 | EP2005951A2 Agent for improving nervous system cell functions |
| 12/24/2008 | EP2005949A1 Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent |
| 12/24/2008 | EP2005948A2 Perfluorocarbon gas transferring emulsion for medico-biological use, the composition and the production method thereof a medicinal agent |
| 12/24/2008 | EP2005945A2 Oseltamivir phosphate granule and preparation mehtod thereof |
| 12/24/2008 | EP2005944A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 12/24/2008 | EP2004854A1 Method of predicting survival of a non-small-cell lung cancer patient to a chemotherapeutic treatment |
| 12/24/2008 | EP2004828A1 Increased phytosterol content through overexpression of an acyl-coa sterol acyltransferase |
| 12/24/2008 | EP2004769A2 Amyloid and amyloid-like structures |
| 12/24/2008 | EP2004693A2 Compositions and methods of use for antibodies of c-met |
| 12/24/2008 | EP2004669A1 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 12/24/2008 | EP2004668A2 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 12/24/2008 | EP2004665A2 Molecules which bind to the dimerization initiation site (dis) of hiv rna, their synthesis and their applications as drugs |
| 12/24/2008 | EP2004661A2 2'-fluoronucleoside phosphonates as antiviral agents |
| 12/24/2008 | EP2004659A1 Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/24/2008 | EP2004658A1 Condensed imidazole derivatives as aromatase inhibitors |
| 12/24/2008 | EP2004657A1 Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 12/24/2008 | EP2004656A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions |
| 12/24/2008 | EP2004655A1 Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4 l)-1-oxo-2,6-dihydro-1h-ý1,2¨diazepinoý4,5,6-cd¨indol-8-yl)acetamide |
| 12/24/2008 | EP2004654A2 Kinase antagonists |
| 12/24/2008 | EP2004653A1 3-SUBSTITUTED N-(ARYL- OR HETEROARYL)-PYRAZO[1,5-a]PYRIMIDINES AS KINASE INHIBITORS |
| 12/24/2008 | EP2004652A1 3-unsubstituted n-(aryl- or heteroarvl)-pyrazolori ý1,5-a¨pyrimidines as kinase inhibitors |
| 12/24/2008 | EP2004649A2 Phenolic hydrazone macrophage migration inhibitory factor inhibitors |
| 12/24/2008 | EP2004648A1 Purine compounds as hsp90 protein inhibitors for the treatment of cancer |
| 12/24/2008 | EP2004647A1 Hiv inhibiting 3,4-dihydro-imidazoý4,5-b¨pyridin-5-ones |
| 12/24/2008 | EP2004646A2 Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor |
| 12/24/2008 | EP2004645A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 12/24/2008 | EP2004643A1 Organic compounds |
| 12/24/2008 | EP2004642A1 Bifunctional polyazamacrocyclic chelating agents |
| 12/24/2008 | EP2004641A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 12/24/2008 | EP2004640A1 Oxazolidinones containing oxindoles as antibacterial agents |
| 12/24/2008 | EP2004634A1 3',5'-di-o-acylated nucleosides for hcv treatment |
| 12/24/2008 | EP2004632A1 Hiv inhibiting 5-amido substituted pyrimidines |
| 12/24/2008 | EP2004631A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases |
| 12/24/2008 | EP2004630A1 2-aminopyrimidin-4-ones and their use for treating or preventing a -related pathologies |
| 12/24/2008 | EP2004629A2 Benzimidazole derivatives |
| 12/24/2008 | EP2004628A2 Acridine derivatives with antitumoral activity |
| 12/24/2008 | EP2004627A2 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |